Plasmology4
US-based Cold Plasma Medical Technologies, Inc., founded in 2010, develops innovative medical devices.
Founded
2010US-based Cold Plasma Medical Technologies, Inc., founded in 2010, develops innovative medical devices.
Plasmology4, originally incorporated as Cold Plasma Medical Technologies, Inc. in 2010 and based in Phoenix, Arizona, is dedicated to developing innovative medical devices. The company's core mission is to harness the fourth state of matter—plasma—to improve patient outcomes globally. Their flagship platform, Plaz4®, offers groundbreaking applications aimed at treating multidrug-refractory bacteria and other medical challenges. Plasmology4 focuses on leveraging advanced plasma technology to address critical healthcare needs, positioning itself at the forefront of medical innovation.
Notable achievements include receiving the FDA's "Breakthrough Device Designation" for their Plaz4® technology, underscoring its potential impact on treating severe bacterial infections. The company has attracted attention from key investors and industry experts due to its pioneering approach and promising results. Plasmology4's advancements in plasma technology have the potential to revolutionize medical treatments, significantly enhancing the quality of life for patients worldwide.
Companies similar to Plasmology4 include Aaplasma, US Medical Innovations, WildSpark Technologies and Sterionics.
Plasmology4 was founded in 2010.
Plasmology4's headquarters is located in Scottsdale, AZ, US.
Plasmology4's most recent funding round was for $250k (USD) in December 2016.
As of Dec 14, 2016, Plasmology4 has disclosed funding of $4.3M (USD). Undisclosed round amounts are excluded.
Plasmology4 has 5 employees as of Feb 5, 2024.
sterionics.com
